These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30515744)

  • 1. Revival of an old stressor: Dobutamine-stimulation for PET myocardial perfusion imaging in patients with end-stage liver disease?
    Schindler TH; Leucker T
    J Nucl Cardiol; 2020 Dec; 27(6):2060-2062. PubMed ID: 30515744
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative blood flow evaluation of vasodilation-stress compared with dobutamine-stress in patients with end-stage liver disease using
    Abele JT; Raubenheimer M; Bain VG; Wandzilak G; AlHulaimi N; Coulden R; deKemp RA; Klein R; Williams RG; Warshawski RS; Lalonde LD
    J Nucl Cardiol; 2020 Dec; 27(6):2048-2059. PubMed ID: 30456495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are Patients With End-Stage Liver Disease Maximally Vasodilated?: Insights From Rubidium-82 PET Dilatory Perfusion.
    Aljizeeri A; Alali Alfaris M; Ahmed D; Farea J; Elneama A; Suliman I; Alharthi M; Ahmed A; Alsaileek A; Al-Mallah M
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2583-2584. PubMed ID: 31542532
    [No Abstract]   [Full Text] [Related]  

  • 4. Semi-quantitative myocardial perfusion measured by computed tomography in patients with refractory angina: a head-to-head comparison with quantitative rubidium-82 positron emission tomography as reference.
    Qayyum AA; Kühl JT; Kjaer A; Hasbak P; Kofoed KF; Kastrup J
    Clin Physiol Funct Imaging; 2017 Sep; 37(5):481-488. PubMed ID: 26625937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary breast cancer diagnosed by 82-Rubidium myocardial perfusion PET-scan.
    Nielsen MØ; Schledermann H; Jensen LT
    J Nucl Cardiol; 2023 Oct; 30(5):2252-2253. PubMed ID: 36795296
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of myocardial blood flow and flow reserve with dobutamine and dipyridamole stress using rubidium-82 positron emission tomography.
    Pelletier-Galarneau M; Ferro P; Patterson S; Ruddy TD; Beanlands RS; deKemp RA
    J Nucl Cardiol; 2021 Feb; 28(1):34-45. PubMed ID: 32449001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stomach interference in
    Rasmussen T; Kjær A; Hasbak P
    J Nucl Cardiol; 2019 Dec; 26(6):1934-1942. PubMed ID: 29968157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rubidium-82 uptake in metastases from pheochromocytoma on PET myocardial perfusion images.
    Gupta A; DiFilippo FP; Brunken RC
    Clin Nucl Med; 2011 Oct; 36(10):930-1. PubMed ID: 21892051
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical PET Flow Reserve Imaging: Is There Precision to Treat Patients or Populations?
    Beanlands RSB; Chong AY; deKemp RA
    JACC Cardiovasc Imaging; 2017 May; 10(5):578-581. PubMed ID: 28017391
    [No Abstract]   [Full Text] [Related]  

  • 11. Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging.
    Ghotbi AA; Kjaer A; Hasbak P
    Clin Physiol Funct Imaging; 2014 May; 34(3):163-70. PubMed ID: 24028171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired myocardial perfusion is associated with increasing end-systolic- and end-diastolic volumes in patients with non-ischemic systolic heart failure: a cross-sectional study using Rubidium-82 PET/CT.
    Byrne C; Hasbak P; Kjaer A; Thune JJ; Køber L
    BMC Cardiovasc Disord; 2019 Mar; 19(1):68. PubMed ID: 30902043
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Van Tosh A; Nichols KJ
    J Nucl Cardiol; 2022 Aug; 29(4):1643-1646. PubMed ID: 33748939
    [No Abstract]   [Full Text] [Related]  

  • 14. Moving towards a better understanding of potential pitfalls in quantitative PET myocardial blood flow.
    Cremer PC; DiFilippo FP; Jaber WA
    J Nucl Cardiol; 2018 Aug; 25(4):1296-1298. PubMed ID: 28229361
    [No Abstract]   [Full Text] [Related]  

  • 15. False-positive stress PET-CT imaging in a patient with interstitial injection.
    Erthal L; Erthal F; Beanlands RSB; Ruddy TD; deKemp RA; Dwivedi G
    J Nucl Cardiol; 2017 Aug; 24(4):1447-1450. PubMed ID: 27519643
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association Between Obstructive Sleep Apnea and Abnormal
    Aneni EC; Thorn SL; Feher A; Hong Chen J; Sinusas AJ; Yaggi HK
    JACC Cardiovasc Imaging; 2023 Jun; 16(6):856-858. PubMed ID: 36881426
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose 3D (82)Rb PET.
    Slomka PJ; Berman DS; Germano G
    J Nucl Cardiol; 2012 Dec; 19(6):1110-2. PubMed ID: 23129187
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter to the editor: Lassen et al. 3D PET/CT
    Renaud JM; Moody JB; Ficaro EP
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2729-2730. PubMed ID: 32651663
    [No Abstract]   [Full Text] [Related]  

  • 20. No major impact of prescribed CAD drugs on myocardial perfusion uptake derived by [
    Werner RA; Rowe SP; Higuchi T
    J Nucl Cardiol; 2022 Dec; 29(6):2863-2865. PubMed ID: 34611851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.